Thursday’s Pre-Market Insights: bluebird bio Inc (BLUE), Best Buy Co Inc (BBY),, inc. (CRM), Transocean LTD (RIG)

bluebird bio Inc (NASDAQ:BLUE) ares increased  3.8% to $179 in pre-market trading after the company announced it will be presenting data on LentiGlobin, a pipeline product, at the 20th Congress of European Hematology Association on June 13. LentiGlobin is a therapy for a rare blood disorder, beta thalassemia.

Best Buy Co Inc (NYSE:BBY) shares increased 10.12% in Thursday’s pre-market trading to $37.20 after the company posted quarterly earnings. Best Buy reported EPS of $0.37, beating the analyst consensus of $0.29. The company also beat the revenue estimate of $8.46 billion and posted $8.56 billion., inc. (NYSE:CRM) shares are up more than 8% to $74.50 after the company reported earnings that surprisingly beat the analyst estimate. Salesforce posted 1Q15 EPS of $0.16, up from $0.11 in the same quarter of last year and above the analyst consensus of $0.14.

Transocean LTD (NYSE:RIG) shares are up 2.80%  to $19.80 after BP reached a settlement with them, as well as Haliburton, regarding the 2010 Deepwater Horizon oil spill in the Gulf of Mexico. BP will pay for damages incurred by Transocean while Transocean will take responsibility for personal injury claims.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts